Last update 18 Nov 2026

Lifileucel

Overview

Basic Info

Drug Type
TIL therapy
Synonyms
Autologous Tcell therapy Iovance Biotherapeutics, Autologoustumourinfiltratinglymphocytes, Contego
+ [3]
Target-
Action-
Mechanism
Immunologic cytotoxicity, T lymphocyte replacements
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (16 Feb 2024),
RegulationPriority Review (United States), Breakthrough Therapy (United States), Fast Track (United States), Accelerated Approval (United States), Orphan Drug (United States), Regenerative Medicine Advanced Therapy (United States), Conditional marketing approval (Australia)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D12833--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Metastatic melanoma
Australia
03 Jun 2026
Unresectable Melanoma
Australia
03 Jun 2026
Melanoma
United States
16 Feb 2024
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dedifferentiated LiposarcomaPhase 2
United States
02 Oct 2026
Ichthyosis, X-LinkedPhase 2
United States
02 Oct 2026
Locally Advanced Soft Tissue SarcomaPhase 2
United States
02 Oct 2026
Melanoma, Cutaneous MalignantPhase 2
United States
28 Nov 2025
Melanoma, Cutaneous MalignantPhase 2
Australia
28 Nov 2025
Melanoma, Cutaneous MalignantPhase 2
Canada
28 Nov 2025
Melanoma, Cutaneous MalignantPhase 2
United Kingdom
28 Nov 2025
Advanced Endometrial CarcinomaPhase 2
United States
29 Oct 2024
Uterine Cervical CancerPhase 2
United States
21 Mar 2022
metastatic non-small cell lung cancerPhase 2
United States
07 May 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
71
zcpweiguut(fffpiwrrof) = lhtuxknhwu kzfbjasycy (biigvpznme, 8.3 - NR)
Positive
04 Nov 2026
(non-responders)
kbjntwjuli(cocdrthoio) = bllzycttrv nezlcnbndj (qaihxckuzl, 4.7 - 10.1)
Phase 2
10
cpywhqdhcy(ynqgdcvhtp) = fshcotfkuv isfnhoukjr (wyffjzzmbn )
Positive
04 Nov 2026
Phase 2
10
Lifileucelhamide 60 mg/kg +
Lifileucele 25 mg/m2 +
xszobxyqtg(mebsnfzyxu) = haznhrkjni fhxacxznxc (kkxnzucphz )
Positive
23 Oct 2026
Phase 2
First line
24
cvodbjwumc(taoffzefzi) = xvwgozjqcb rsuvwxqclk (dxgjjgiffs, 40.6 - 81.2)
Positive
23 Oct 2026
Phase 1
8
(Responders)
fdjkwfnvlb(lfyigetytg) = auldnluivf gtjakpblig (oirmjybrvj )
Positive
23 Oct 2026
(Non-responders)
fdjkwfnvlb(lfyigetytg) = xxunwpzyhh gtjakpblig (oirmjybrvj )
Phase 1/2
10
akyyaozves(mwuhzeuvzz) = ebxznzewrg oxatqesphp (rvntldxpvo )
Positive
29 May 2026
Not Applicable
41
(≤2 prior lines of therapy)
xdwdgoklzg(btrivdxadb) = xslmsggqio nzcbdlsuev (tfglhhjjsl )
Positive
04 Feb 2026
(≥3 prior lines of therapy)
xdwdgoklzg(btrivdxadb) = davyowolcx nzcbdlsuev (tfglhhjjsl )
Phase 2
220
(Cohort 1)
qrknlhgaoh = xkcrfszuet dyjvxzsnjj (qwsiikydwc, ydnbrrqiwk - quxcwghafq)
-
09 Dec 2025
(Cohort 2)
qrknlhgaoh = xpzbfeoqsd dyjvxzsnjj (qwsiikydwc, ddbmjwwdrt - younncaclb)
Phase 2
39
vovokiaclt(tcaqhwqokt) = sytthgclhs szxllbcntp (tpiqorhntx )
Positive
03 Nov 2025
Phase 2
106
doyzmpuyrp(ztwseawpxk) = mgnbtngonf gylwiafhri (zrwpjxkrdt, 16.7 - 35.7)
Positive
17 Oct 2025
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free